Kirk E. Hevener, PharmD, PhD

A new study demonstrated that gut organisms can alter drug availability by biotransformation on a significantly broader scale than previously expected.

A recent study reported the benefit of vaginal microbiome transplantation for the treatment of recurrent bacterial vaginosis.

A recent study provides what may be the first in-depth examination of the molecular mechanism of biotransformation of a large number of orally administered agents by the human gut microbiota.